跳至主要内容
临床试验/NCT04600180
NCT04600180进行中(未招募)不适用

Deep Phenotyping of the Gut Immune System During Immune Checkpoint Inhibitor Therapy - DEFENCE

University Medical Center Groningen1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2021年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
38
试验地点
1
主要终点
CD8+ T cell count in the gut mucosa

研究概览

简要总结

This exploratory study aims to gain insight in gut immune system phenotypes before and after immunotherapy. After informed consent is obtained, sigmoidoscopies at baseline and during treatment with immunotherapy will be performed, During the endoscopies, biopsies from the sigmoid and rectum will be obtained. Subsequent immune cell analyses in these biopsies will be performed. Parallel to the sigmoidoscopies, venous blood samples will be obtained to monitor inflammatory markers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for treatment with anti PD1/PDL1 based immunotherapy
  • Written informed consent
  • Evaluable according to iRECIST v1.1

排除标准

  • Concomitant, chronic or infectious illness in the past 6 months causing moderate to severe colitis
  • Use of a medication in the past 6 months with an elevated risk of moderate to severe colitis
  • Gastrointestinal resection or enterostomy
  • Abdominal radiotherapy in the past 6 months

结局指标

主要结局

CD8+ T cell count in the gut mucosa

时间窗: 8 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验